-
From Ibukun Ifelayo on July 9th, 2020
0 likes 25 playsWelcome-Dorothy Lewis, PhD, Faculty Development Program Director Course Overview - Course director: Christopher Lincoln, PhD - Director, Office of Translational… -
From Ibukun Ifelayo on July 10th, 2020
0 likes 11 playsWelcome- Dorothy Lewis, PhD, Faculty Development Program DirectorResearch Integrity and Record keeping, Patrick Weitzel, PhD, HMRI Office of Research Integrity -
From Ibukun Ifelayo on July 16th, 2020
0 likes 7 playsIntroduction to Drug, Device, Biologic and Combination Product PathwayChristina Talley, MS, RAC, CCRP, CCRCDirector, Office of Regulatory Affairs and Translational… -
From Ibukun Ifelayo on July 30th, 2020
0 likes 9 playsTarget Product Profile (TPP): A Strategic Development Process ToolChristina Talley, MS, RAC, CCRP, CCRCDirector, Office of Regulatory Affairs and Translational… -
From Ibukun Ifelayo on August 26th, 2020
1 likes 9 playsQuality Risk Management & Quality Development Through GLP Safety Studies by Russell Wilson -
From Ibukun Ifelayo on September 3rd, 2020
0 likes 12 playsTranslational Pathways & Manufacturing through GLP-Safety -
From Ibukun Ifelayo on September 10th, 2020
0 likes 7 playsMoving from Basic Research to GLP Safety Studies with Tanya Herzog, DVM, DACLAM -
From Ibukun Ifelayo on October 6th, 2020
0 likes 6 playsGMP Manufacturing for Clinical Use by Daniel J. Kota, PhD. -
From Ibukun Ifelayo on October 8th, 2020
0 likes 3 plays -
From Ibukun Ifelayo on October 22nd, 2020
0 likes 5 plays -
From Ibukun Ifelayo on November 11th, 2020
0 likes 3 playsConcept to Commercialization Session 11 Device Translation: Lessons Learned” by Francesca Taraballi, PhD.
© 2021. Houston Methodist, Houston, TX. All rights reserved. | Website Privacy Disclaimer User Guides and Technical Documentation